Opportunités Business

Looking for technology to develop a medical device for non-invasive diagnosis of prodromal Alzheimer’s

A Dutch company offers a new way of looking at Alzheimer’s development by applying (epi-)genetics-based knowledge to factors that epidemiologically and/or experimentally have been linked to Alzheimer's development


Publié le

21 octobre 2020

Date de clôture

28 février 2021

Lieu(x)

PAYS-BAS

Marché(s) cible(s)

Dispositifs médicaux

Type de collaboration recherchée

Partenaire


For project second phase, the company is looking for a partner experienced in biosensor/like technology to develop a simple inexpensive device for screening, diagnosis and efficacy follow-up during drug development, within the frame of a joint venture or a license agreement.

Partner type: (preferentially Biotech company) experienced in biosensor, biosensor/like or equivalent innovative technology allowing for detection of a microRNA profile in human blood, plasma or serum for diagnosis based on a specific algorithm.

The partner is expected to develop a biosensor, biosensor/like or equivalent allowing for detection of a microRNA profile at levels of pico tot femtogram’s per millilitre in human blood, plasma or serum for diagnosis based on a specific algorithm.

Certification standards (ISO 13485) and compliance with Directive 98/79/EU under the Commission Implementing Decision (EU) 2020/439 are requested

If you are interested, ask to be put in touch with an advisor who can tell you more about this business opportunity and how to position yourself.